CD69 and rheumatoid arthritis: Furthermore, we show that CD69+FoxP3+ and TIGIT+FoxP3+ Treg subsets are induced by VD3-primed DCs, which are especially beneficial for the targeted suppression of pathogenic Th17 cell responses that contribute to disease progression in psoriasis and rheumatoid arthritis, among others (1, 2).